Metabolic effects of isradipine in non-insulin-dependent diabetes mellitus (NIDDM) hypertensive patients
β Scribed by L. A. Ferrara; G. Simone; R. Iannuzzi; I. Gaeta; G. D'Orta; S. Turco; L. Guida; T. Marotta
- Publisher
- Springer US
- Year
- 1995
- Tongue
- English
- Weight
- 154 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0920-3206
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Newer therapeutic approaches are being employed for the treatment of diabetes mellitus, and among these, acarbose, an Ξ±-glucosidase inhibitor, has proven effective in lowering postprandial blood glucose levels and glycosylated hemoglobin. The aim of the present study was to evaluate the effects of
Identification of risk factors for development of diabetic sensorimotor peripheral neuropathy (DSPN) and diabetic autonomic neuropathy (DNA) may help to prevent or modify these complications. The ABCD Trial, a prospective study of diabetic complications, has identified risk factors of the presence a
Diabetic patients with elevated urinary albumin excretion rate (incipient or clinical nephropathy) also have an increased transcapillary escape rate of albumin. This study was designed to clarify whether this is caused by a general vascular dysfunction or by elevated systemic blood pressure. The sys
This study examined the pharmacokinetics of theophylline and formation of its metabolites in patients with insulin-dependent diabetes mellitus (IDDM) and in sex-, age-, and weight-matched healthy nonsmokers (n = 8 per group). Subjects received a single dose of 5 mgikg theophylline From the